Drugs Health Medical Pharma

FDA warns against use of Fast-act and UA-Block capsules to treat rheumatism

The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Research shows balanced gut bacteria can ease rheumatoid arthritis pain

HQ Team

May 11, 2023: The FDA has warned consumers against using fast-act rheum and UA-Block capsules to treat inflammation and joint pains as they contain substances that raise blood sugar, heart attacks, and stroke risk.

The fact-act rheum capsule for rheumatoid arthritis is sold through various websites and possibly in some retail stores.

FDA laboratory analysis confirmed that the capsules contain non-steroidal anti-inflammatory drugs(NSAID) not listed on the product labels. The FDA laboratory analysis also confirmed that the capsule contains prednisone-21-acetate and piroxicam

Consumers taking fast-act rheuma capsules should immediately consult with their healthcare professional to safely discontinue the use of this product. A healthcare professional should assess the risks of withdrawal from corticosteroids. Only licensed healthcare professionals can evaluate patients for risk or confirm the existence of adrenal suppression.

High blood sugar

Prednisone-21-acetate is a corticosteroid. Corticosteroid use can impair a person’s ability to fight infections and can cause high blood sugar levels, muscle injuries, and psychiatric problems. 

When corticosteroids are taken for a prolonged period or at high doses, they can suppress the adrenal gland. Abrupt discontinuation can cause withdrawal symptoms.

Piroxicam, an NSAID,  may cause an increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. 

This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.

Indomethacin

The New Fast-Act Rheumatism capsule, a product used for joint pain and arthritis, contains indomethacin not listed on the product label. 

Indomethacin is a non-steroidal anti-inflammatory drug (NSAID). NSAIDs may cause an increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. 

The drug regulator also advised consumers not to purchase or use UA-Block, a product promoted and sold for joint pain and inflammation, pain from gout, and liver detoxification.

Leave a Reply

Your email address will not be published. Required fields are marked *